A preference trial with naratriptan 2.5 mg and paracetamol 1000 mg in migraine patients in the general practice
Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 06 Jan 2009
At a glance
- Drugs Naratriptan; Paracetamol
- Indications Migraine
- Focus Therapeutic Use
- 06 Jan 2009 New source identified and integrated (Netherlands Trial Register).
- 11 Dec 2005 New trial record.